GBI Research, Sep 2011, Pages: 85
“Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013”, provides in-depthanalysis of trends, issues and challenges in this industry
GBI Research, Dec 2011, Pages: 76
and BRIC (Brazil, Russia, India and China) countries are also provided. Key cost and developmental issues are also addressed. The report provides an in-depthanalysis of the competitive landscape, including
Pharma-Reports, Sep 2011, Pages: 91
materials, packing materials, and pharmaceutical machinery.
This report examines the Chinese Pharmaceutical Industry in-depth and focuses on the impact the WTO accession of China has had on the Chinese
Research In China, Dec 2010, Pages: 52
of China’s chemical pharmaceutical industry and its sub-sectors, but also makes an in-depthanalysis of the operation and development advantages of China’s ten leading active pharmaceutical ingredient
Select Biosciences Ltd, June 2011, Pages: 222
for establishing new ventures. The research will help consultants, industry analysts, and vendors to get in-depth knowledge of the current, past, and future performance of the emerging pharmaceutical markets
Research In China, Dec 2010, Pages: 52
of China’s chemical pharmaceutical industry and its sub-sectors, but also makes an in-depthanalysis of the operation and development advantages of China’s ten leading active pharmaceutical ingredient
Taiyou Research, Nov 2011, Pages: 240
of the industry, the pharmaceutical sales channels, and the expansion and consolidation of pharmacies in China are all analyzed in this section.
Following on from an analysis of the healthcare reforms in China
GBI Research, Dec 2009, Pages: 62
, key trends analysis on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging is detailed.
This report is built using data and information sourced from proprietary
GBI Research, Aug 2011, Pages: 108
“Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force”, provides in-depthanalysis of trends, issues
Datamonitor, Jan 2011, Pages: 791
MARKET SHARE
FIVE FORCES ANALYSIS
LEADING COMPANIES
MARKET FORECASTS
MACROECONOMIC INDICATORS
PHARMACEUTICALS IN CHINA
MARKET OVERVIEW
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
Plimsoll Publishing Ltd., Feb 2012, Pages: 560
The Global Pharmaceuticals Industry Report
This report is an in-depth financial evaluation of the global Pharmaceuticals industry. Using the unique Plimsoll method of analysis, each of the top 500
Datamonitor, March 2011, Pages: 74
The China: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the ChinaPharmaceuticals industry. It includes detailed data on market size
CCM International Limited, July 2010, Pages: 51
of paclitaxel injection production and its manufacturers
- Top 2 pharmaceutical distribution companies in China
- Medicine bidding and purchasing platforms
- Import and export paclitaxel injection analysis
Datamonitor, Feb 2010, Pages: 68
The Pharmaceuticals: China Industry Guide is an essential resource for top-level data and analysis covering the ChinaPharmaceuticals industry. It includes detailed data on market size
GBI Research, June 2011, Pages: 95
- Counterfeiting Poses Threats to Patient Safety and Revenues of Pharmaceutical Companies”, provides in-depthanalysis of trends, issues and challenges in this industry. The report analyzes the effects
JZMed Inc., May 2011, Pages: 230
and in-depth comparisons of the drug formulation industries between China and India. It has revealed the relative positions of China and India in the global pharmaceutical supply chain.
- The report also
GBI Research, Jan 2011, Pages: 122
in China 53
5.5.2 Reimbursement of Drugs in China 55
5.6 Key Takeaway 57
6 Oncology in China – Pipeline Analysis 58
6.1 Key Area Focused for R&D in China 58
6.1.1 Trend of R&D Investment by Pharmaceutical
JZMed Inc., July 2008, Pages: 162
research industry (CROs)
3.3.4 China’s contract pharmaceutical manufacturing industry (CMOs)
Chapter 4. How to best use the resources readily available in ChinaAnalysis of Strategies
4.1 Introduction
4
Datamonitor, Nov 2010, Pages: 985
MARKET FORECASTS
MACROECONOMIC INDICATORS
OTC PHARMACEUTICALS IN CHINA
MARKET OVERVIEW
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
LEADING COMPANIES
GBI Research, Nov 2010, Pages: 65
informed business decisions from the insightful and in-depthanalysis of the Indian pharmaceutical analytical services market and the factors shaping it. “Pharmaceutical Analytical Services Outsourcing
